Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics, Safety, Tolerability and Efficacy of Entecavir in HBeAg-Positive Pediatric Chronic Hepatitis B
2005-005816-26Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Bristol Myers Squibb. Primary endpoint: Pharmacokinetic parameters. Started Jun 2007; status: completed.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2005-005816-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005816-26.